Vivian Marlowe
Alcohol abuse is a serious condition that can lead to health problems and even premature death. To diagnose and treat alcohol-related problems effectively, clinicians use biochemical measurements and biomarkers to assess a patient's current or past alcohol consumption. Blood is the most commonly used sample for laboratory measurements, and specific biomarkers are generally detectable in the blood earlier than in other biospecimens. When it comes to detecting alcoholism, there are several lab markers that can indicate excessive alcohol use, including increased levels of GGT, CDT, MCV, AST, and ALT. These markers reflect the activity of certain
| Characteristics | Values |
|---|---|
| Blood Biomarkers | Ethanol, Ethyl glucuronide (EtG), Ethyl sulfate (EtS), Carbohydrate-deficient transferrin (CDT), Phosphatidylethanol (PEth), Gamma-glutamyl transferase (GGT), Mean corpuscular volume (MCV), Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) |
| CDT Blood Test | Indicates long-term, heavy alcohol use (≥40 g/day for up to 2 weeks) or relapse. CDT levels are higher in heavy drinkers. |
| GGT | Increased GGT levels may be detected before the development of alcohol-related liver injury, making it a useful early intervention marker. |
| MCV | Increased MCV is less sensitive but more specific than GGT in indicating alcohol abuse. |
| Other Potential Biomarkers | Cytokines, Total serum sialic acid (TSA), 5-hydroxytryptophol (5-HTOL), N-acetyl-beta-hexosaminidase (Beta-Hex), Plasma sialic acid index of apolipoprotein J (SIJ), Salsolinol, Acetaldehyde, Fatty acid ethyl esters (FAEE) |
Explore related products
![ETG Alcohol Urine Test Strips, High Sensitivity | Cut-Off, 80 Hour Detection Window, Rapid 2-Minute Results for Home/Workplace/Rehab Testing [8 Pack]](https://m.media-amazon.com/images/I/61aUeQBtEEL._AC_UL320_.jpg)
What You'll Learn
- Ethanol, ethyl glucuronide, and ethyl sulphate are markers for acute alcohol ingestion
- Carbohydrate-deficient transferrin and phosphatidylethanol are markers for chronic alcohol use
- Blood biomarkers are influenced by comorbid physical and/or mental health problems
- Laboratory tests help detect current intoxication levels and regular alcohol consumption
- Blood biomarkers are more commonly used than other biospecimens, such as urine, saliva, and hair
Ethanol, ethyl glucuronide, and ethyl sulphate are markers for acute alcohol ingestion
Laboratory tests for acute alcohol ingestion include ethanol, ethyl glucuronide (EtG), and ethyl sulfate (EtS). Ethanol is a type of alcohol and the main psychoactive drug found in alcoholic drinks. It is also a byproduct of the metabolic process, created by the fermentation of sugars by yeasts, some bacteria, and some fungi.
Ethyl glucuronide and ethyl sulfate are both metabolites of ethanol. Metabolites are the byproducts of the body's metabolic process, which involves breaking down and assimilating substances that enter the body. EtG and EtS are detectable for longer in urine than breath ethanol or urine ethanol after alcohol intake. EtG and EtS are considered good markers of acute, short-term alcohol ingestion (up to 36 hours in the blood, and up to 5 days in urine).
EtG is a direct marker of alcohol abuse, and is only detected in urine when alcohol is consumed and metabolized by the liver. It is also a more sensitive marker than breathalyser or self-reports to detect covert short-term relapses into drinking. However, false negatives can occur due to bacterial degradation, and false positives can occur from in vitro bacterial conjugation of glucuronide to ethanol.
EtS has the same advantages as EtG, but is more stable in urine at room temperature. It is also a metabolite of ethanol in humans and a potential biomarker of acute alcohol intake.
Prohibition and Repeal: Amendments in Focus
You may want to see also
Explore related products
Carbohydrate-deficient transferrin and phosphatidylethanol are markers for chronic alcohol use
Laboratory tests are often used to detect alcohol use, with blood being the most common sample for laboratory measurements. Carbohydrate-deficient transferrin (CDT) is a biomarker for chronic alcohol intake, with a consumption of over 60 g of ethanol per day for 2-3 weeks or longer. CDT is a more specific marker than other widely available biochemical tests for alcohol abuse, with a sensitivity of 95% and a specificity of 93.3%. It is particularly useful in detecting alcoholic hepatitis and liver failure. CDT values are influenced by body mass index (BMI), female sex, and smoking, and are not markedly affected by medication.
Phosphatidylethanol (PEth) is another marker for chronic alcohol use. It is a direct ethanol metabolite and can be detected in the blood for up to two weeks of sobriety. PEth testing is useful for monitoring alcohol consumption, identifying early signs of harmful consumption, and tracking cases of alcohol use disorder (AUD) or dependence. PEth is also useful in monitoring abstinence after long-term alcohol use.
Both CDT and PEth are specific markers for chronic alcohol use, and can be used in combination with other biomarkers such as gamma-glutamyl transferase (GGT) and mean corpuscular volume (MCV) to improve diagnostic sensitivity and specificity. These biomarkers are useful tools in the detection and management of alcohol use and related disorders.
Naming Benzene Rings with Alcohol Groups: A Comprehensive Guide
You may want to see also
Explore related products
Blood biomarkers are influenced by comorbid physical and/or mental health problems
Blood biomarkers are an effective way to detect alcohol abuse and can be used to diagnose alcohol use disorder (AUD). The blood is the most commonly used sample for laboratory measurements in general practice and primary care settings. However, it's important to note that the sensitivity and specificity of blood biomarkers can be influenced by comorbid physical and/or mental health problems. This means that the results of these biomarkers must be interpreted alongside self-reported measures, patient history, and a physical exam to provide an accurate assessment of alcohol use.
One of the most widely used blood biomarkers for detecting alcohol abuse is gamma-glutamyl transferase (GGT). GGT levels in the blood can increase before the development of alcohol-related liver injury, making it a useful marker for early intervention. It is also a sensitive marker for detecting active alcoholism, especially in patients hospitalized for treatment of withdrawal symptoms. However, GGT alone may not be sufficient, and combining it with other biomarkers like carbohydrate-deficient transferrin (CDT) can provide a higher diagnostic sensitivity and specificity.
CDT is another important biomarker that indicates long-term, heavy alcohol use. It is a serum marker of ethanol consumption and can be useful for monitoring abstinence after long-term use. CDT levels generally correlate well with an individual's drinking pattern, especially during the preceding 30 days. However, it is important to note that factors such as body mass index (BMI), female sex, and smoking can affect CDT levels.
Other blood biomarkers that can indicate alcohol intake include aspartate aminotransferase (AST), alanine aminotransferase (ALT), and mean corpuscular volume (MCV). MCV is a less sensitive but more specific marker than GGT and can be useful in estimating the duration and extent of drinking episodes in heavy-drinking patients. Additionally, biomarkers such as ethyl glucuronide (EtG), ethyl sulfate (EtS), and fatty acid ethyl esters (FAEE) are specific markers for detecting acute alcohol exposure and short-term alcohol ingestion.
While these blood biomarkers provide valuable information, they should be interpreted within the context of the patient's overall health and history. This includes considering any comorbid physical or mental health issues that may impact the sensitivity and specificity of the biomarkers. By combining laboratory values with self-reported measures and a comprehensive patient assessment, healthcare providers can more accurately diagnose and treat alcohol use disorders.
The Best Way to Send Alcohol Gifts to Georgia
You may want to see also
Explore related products
Laboratory tests help detect current intoxication levels and regular alcohol consumption
Laboratory tests can be used to detect current intoxication levels and regular alcohol consumption. Blood alcohol concentration (BAC) tests are the most common way to determine the amount of alcohol in a person's blood and how much it is affecting them. BAC tests can be used by law officials to see if someone drank while underage, broke a parole agreement, or drove while above the legal BAC limit. A BAC of over 250 mg/dL is considered toxic and may result in loss of motor function, impaired consciousness, respiratory depression, and death. A BAC of 0.30% or higher is considered alcohol poisoning, and a BAC of 0.40% or higher is especially dangerous and may be fatal.
Other blood tests can measure substances that may stay in the blood for weeks after alcohol consumption. These tests can be used to monitor treatment for alcohol use disorder (AUD) and to detect early signs of harmful alcohol consumption. Serum ethanol testing provides the most accurate determination of a person's alcohol level, but it is not reliable beyond the first 6-8 hours. Ethanol, ethyl glucuronide (EtG), and ethyl sulfate (EtS) tests are used to detect acute alcohol ingestion. EtG and EtS are considered good markers of acute, short-term alcohol ingestion (up to 36 hours in the blood and up to 5 days in urine). Carbohydrate-deficient transferrin (CDT) and phosphatidylethanol (PEth) are markers for monitoring abstinence after long-term alcohol use. PEth can detect longer-term exposure (within 1-2 weeks or longer) and is closely correlated with alcohol consumption.
Other potential markers for alcohol consumption include gamma-glutamyl transferase (GGT), mean corpuscular volume (MCV), aspartate aminotransferase (AST), and alanine aminotransferase (ALT). However, these markers are considered nonspecific, as they may be elevated due to other factors such as nonalcoholic fatty liver disease, drug intoxication, obesity, diabetes, and hepatobiliary disorders. Laboratory tests for toxic alcohols such as acetone, isopropanol, and methanol are also available, but they are not used for the initial evaluation of potential toxicity. Gas chromatography is typically used to measure these toxic alcohols, but this method may not be available in all healthcare settings.
Louisiana's Legal Alcohol Limit Explained
You may want to see also
Explore related products
Blood biomarkers are more commonly used than other biospecimens, such as urine, saliva, and hair
Blood biomarkers are often preferred over other biospecimens such as urine, saliva, and hair. This is because blood is the most commonly used sample for laboratory measurements in general practice and primary care settings. In the context of alcohol use, blood biomarkers are detectable earlier and offer a wider range of detection compared to other biospecimens.
Blood biomarkers are also useful in detecting alcohol use disorders (AUD) and monitoring abstinence. For example, carbohydrate-deficient transferrin (CDT) is a serum marker of long-term, heavy alcohol use or relapse. CDT concentrations generally correlate well with an individual's drinking pattern and are useful for monitoring long-term abstinence. Similarly, phosphatidylethanol (PEth) is a direct ethanol metabolite that can be tested to detect longer-term exposure. Blood PEth levels are closely correlated with alcohol consumption, making it a valuable tool for monitoring alcohol consumption, identifying early signs of harmful alcohol use, and tracking cases of AUD or dependence.
In addition, blood biomarkers can provide a more accurate assessment of alcohol use when combined with self-reported measures and interpreted alongside an individual's history and physical exam. However, it is important to note that the sensitivity and specificity of blood biomarkers can be influenced by comorbid physical and mental health problems, such as metabolic disorders, liver diseases, cardiovascular diseases, and mood disorders.
While blood biomarkers are commonly used, other biospecimens such as urine, saliva, and hair can also be examined to detect alcohol use. For example, the concentration of fatty acid ethyl esters in hair has been studied as a biomarker for alcohol use, and ethanol can be detected in urine for up to 5 days after ingestion.
In other areas of medicine, such as oncology, blood biomarkers are also widely used. They can be used to detect cancer-specific biomarkers, such as mutant proteins, which provide excellent specificity for medical purposes. Liquid biopsies, which involve analyzing blood samples for circulating tumor DNA (ctDNA), have become increasingly popular due to their ability to generate large volumes of data quickly and cost-effectively. Additionally, in cases of metastatic colorectal cancer, predictive blood biomarkers can help evaluate and improve patient survival rates and spare patients from unnecessary toxicity associated with certain treatment plans.
Alcohol Headaches: Why Some Suffer and Others Don't
You may want to see also
Frequently asked questions
A yellow flag for alcoholism is when an individual has a blood-alcohol concentration of over 250 mg/dL. Other laboratory markers indicating long-term alcohol use include carbohydrate-deficient transferrin (CDT) and phosphatidylethanol (PEth).
The CDT blood test is a carbohydrate-deficient transferrin test that can be used to detect heavy drinking. It is a highly accurate marker of excessive alcohol use and can be used to diagnose an alcohol use disorder.
Phosphatidylethanol (PEth) is a direct ethanol metabolite and can be tested to detect longer-term exposure (within 1-2 weeks or longer). It is a useful marker for monitoring abstinence after long-term use.
Other markers that indicate alcohol use include gamma-glutamyl transferase (GGT), mean corpuscular volume (MCV), aspartate aminotransferase (AST), and alanine aminotransferase (ALT).
